There is scientific knowledge. And there is public perception. And often, the two collide. Nowhere is this reality more explicit than with the current state of Alzheimer’s disease research. Without a definitive cause or diagnosis – and no cure in sight – many adults see no reason to assess their risk, or determine their cognitive status, if little can be done to stave off the disease. These perceptions present a growing challenge to clinical trial enrollment and Alzheimer’s research overall.
This webinar explores the:
- Current status of global Alzheimer’s disease research
- Patient and caregiver perceptions and motivations that influence clinical trial participation
- Barriers to enrolling patients in clinical trials and strategies to overcome these barriers
- Benefits of online self-assessments and longitudinal screening
Join hundreds of industry colleagues and learn about innovative methods to enrolling Alzheimer’s clinical trials and advancing research for this global health crisis.